Clarification on Price Movement in the Equity Shares of Godavari Drugs Limited
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Drugs Limited responded to a BSE query seeking clarification on a significant movement in the price and/or volume of its shares. The company confirmed that it does not possess any unpublished price sensitive information (UPSI) that could explain the movement. It stated that the price movement appears to be purely market-driven, based on demand and supply factors, over which the company has no control. The company also affirmed that it maintains adequate internal controls and is in compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine regulatory clarification and does not indicate any negative development. For shareholders, it suggests no hidden corporate action or undisclosed event is behind the price movement, though the lack of a specific reason may leave the stock susceptible to continued volatility driven by market sentiment alone.